arrow
S

Steven M. Pollard

University of Edinburgh
H指数:48
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sequential Design of Activatable Photosensitizers for Ablation of Glioma Cells in Brain Cancer Tissues

用于脑癌组织中胶质瘤细胞消融的可激活光敏剂的顺序设计

2026-10-010
OAAI
A comprehensive pharmacological survey across heterogeneous patient-derived glioblastoma stem cell models

异质性患者源性胶质母细胞瘤干细胞模型的全面药理学调查

2026-04-270
OAAI
Synthetic super-enhancers enable precision viral immunotherapy

合成超级增强子实现了精准病毒免疫疗法

Nature
IF48.5
2026-04-080
OAAI
Steroid-dependent metabolic rewiring reveals novel therapeutic and imaging approaches for glioblastoma

类固醇依赖性代谢重组揭示了胶质母细胞瘤的新治疗和成像方法

2026-01-230
OAAI
Single cell proteomic analysis defines discrete neutrophil functional states in human glioblastoma

单细胞蛋白质组学分析确定了人类胶质母细胞瘤中离散的中性粒细胞功能状态

2025-12-150
OA
Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies

调节性T细胞耗竭促进髓系细胞活化及胶质母细胞瘤对anti-PD1和肿瘤靶向抗体的反应

Immunity
IF26.3
2025-05-290
OA
Nucleosome fibre topology guides transcription factor binding to enhancers

核小体纤维拓扑结构指导转录因子结合增强子

Nature
IF48.5
2024-12-180
OAAI
An ILK/STAT3 pathway controls glioblastoma stem cell plasticity

ILK/STAT3通路调控胶质母细胞瘤干细胞可塑性

2024-12-012
OAAI
TRANSLATIONAL STEPS OF THE ANTITUMOR PEPTIDE TAT-CX43266-283 AS A TREATMENT FOR GLIOBLASTOMA: EGFR AS A TREATMENT RESPONSE BIOMARKER AND RESULTS OF COMBINATION THERAPY IN A PRECLINICAL RESECTION MODEL
2024-11-110
PRE